(Q38547040)

4 September 2017

1 reference

title

Personalized cancer immunotherapy using Systems Medicine approaches (English)

1 reference

4 September 2017

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26174229%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Ulf Schmitz

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26174229%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Julio Vera

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26174229%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

author name string

Tanushree Jaitly

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26174229%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Gerold Schuler

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26174229%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Olaf Wolkenhauer

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26174229%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

publication date

14 July 2015

1 reference

Briefings in Bioinformatics

4 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26174229%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26174229%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26174229%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

page(s)

453-467

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26174229%20AND%20SRC:MED&resulttype=core&format=json

Survivin-specific T-cell reactivity correlates with tumor response and patient survival: a phase-II peptide vaccination trial in metastatic melanoma

14 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

PROVENGE (Sipuleucel-T) in prostate cancer: the first FDA-approved therapeutic cancer vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Sipuleucel-T immunotherapy for castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

gp100 peptide vaccine and interleukin-2 in patients with advanced melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Designing vaccines based on biology of human dendritic cell subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Epstein-barr virus vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: a follow-up study at 15 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Clinical outcomes of a novel therapeutic vaccine with Tax peptide-pulsed dendritic cells for adult T cell leukaemia/lymphoma in a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Cancer immunotherapy in clinical practice -- the past, present, and future.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Harnessing the antigenic fingerprint of each individual cancer for immunotherapy of human cancer: genomics shows a new way and its challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Somatically mutated tumor antigens in the quest for a more efficacious patient-oriented immunotherapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Bioinformatics for cancer immunology and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Bioinformatics for cancer immunotherapy target discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Genomic and bioinformatic profiling of mutational neoepitopes reveals new rules to predict anticancer immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Neoantigens in cancer immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Precision cancer immunotherapy: optimizing dendritic cell-based strategies to induce tumor antigen-specific T-cell responses against individual patient tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

The three-dimensional structure of peptide-MHC complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

A global insight into a cancer transcriptional space using pancreatic data: importance, findings and flaws.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

IPD--the Immuno Polymorphism Database

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

IMGT, the international ImMunoGeneTics information system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

CTdatabase: a knowledge-base of high-throughput and curated data on cancer-testis antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

The immune epitope database 2.0.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

International Cancer Genome Consortium Data Portal--a one-stop shop for cancer genomics data

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

COSMIC: exploring the world's knowledge of somatic mutations in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

A mutated HLA-A2 molecule recognized by autologous cytotoxic T lymphocytes on a human renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

T cells associated with tumor regression recognize frameshifted products of the CDKN2A tumor suppressor gene locus and a mutated HLA class I gene product

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Tumor-specific shared antigenic peptides recognized by human T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Cancer/testis antigens, gametogenesis and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Phase I/II trial of a dendritic cell vaccine transfected with DNA encoding melan A and gp100 for patients with metastatic melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Cancer-testis and melanocyte-differentiation antigen expression in malignant glioma and meningioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Tumor-associated antigens for specific immunotherapy of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Non-conventional sources of peptides presented by MHC class I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

HLA-binding properties of tumor neoepitopes in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

An introduction to epitope prediction methods and software

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

QSAR method for prediction of protein-peptide binding affinity: application to MHC class I molecule HLA-A*0201.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Methods and protocols for prediction of immunogenic epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

T-cell epitope vaccine design by immunoinformatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Predicting protein function from sequence and structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Prediction of protein antigenic determinants from amino acid sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Antigenic determinants in proteins coincide with surface regions accessible to large probes (antibody domains).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Continuous and discontinuous protein antigenic determinants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Predictive estimation of protein linear epitopes by using the program PEOPLE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Sequence features that correlate with MHC restriction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Poor correspondence between predicted and experimental binding of peptides to class I MHC molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Using the World Wide Web for predicting CTL epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

In silico methods for predicting T-cell epitopes: Dr Jekyll or Mr Hyde?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Precise prediction of major histocompatibility complex class II-peptide interaction based on peptide side chain scanning

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Bioinformatics tools for identifying class I-restricted epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Enhancement to the RANKPEP resource for the prediction of peptide binding to MHC molecules using profiles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

EpiJen: a server for multistep T cell epitope prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

ProPred: prediction of HLA-DR binding sites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Hidden Markov Models and their Applications in Biological Sequence Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Predicting peptides that bind to MHC molecules using supervised learning of hidden Markov models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Prediction of promiscuous peptides that bind HLA class I molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Prediction of MHC class I binding peptides by a query learning algorithm based on hidden markov models

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Prediction of MHC class II-binding peptides using an evolutionary algorithm and artificial neural network.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Reliable prediction of T-cell epitopes using neural networks with novel sequence representations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

NetMHC-3.0: accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8-11

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Application of support vector machines for T-cell epitopes prediction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

SVM based method for predicting HLA-DRB1*0401 binding peptides in an antigen sequence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Prediction of linear B-cell epitopes using amino acid pair antigenicity scale.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Predicting linear B-cell epitopes using string kernels

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

AlgPred: prediction of allergenic proteins and mapping of IgE epitopes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

COBEpro: a novel system for predicting continuous B-cell epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Modeling the structure of bound peptide ligands to major histocompatibility complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

New ligands binding to the human leukocyte antigen class II molecule DRB1*0101 based on the activity pattern of an undecapeptide library

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Peptide binding specificity of major histocompatibility complex class I resolved into an array of apparently independent subspecificities: quantitation by peptide libraries and improved prediction of binding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

CrossTope: a curate repository of 3D structures of immunogenic peptide: MHC complexes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

EpiDOCK: a molecular docking-based tool for MHC class II binding prediction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Prediction of residues in discontinuous B-cell epitopes using protein 3D structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Toward prediction of binding affinities between the MHC protein and its peptide ligands using quantitative structure-affinity relationship approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Development of proteo-chemometrics: a novel technology for the analysis of drug-receptor interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Peptide binding to the HLA-DRB1 supertype: a proteochemometrics analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Structural prediction of peptides binding to MHC class I molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Structure-based prediction of MHC-peptide association: algorithm comparison and application to cancer vaccine design.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

ElliPro: a new structure-based tool for the prediction of antibody epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Selection of peptide ligands for the antimucin core antibody C595 using phage display technology: definition of candidate epitopes for a cancer vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

PSMA mimotope isolated from phage displayed peptide library can induce PSMA specific immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

High-molecular-weight melanoma-associated antigen mimotope immunizations induce antibodies recognizing melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Targeting melanoma cells with human high molecular weight-melanoma associated antigen-specific antibodies elicited by a peptide mimotope: functional effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Mimotope vaccination for epitope-specific induction of anti-VEGF antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Improving T cell responses to modified peptides in tumor vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

MIMOX: a web tool for phage display based epitope mapping

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

MimoDB 2.0: a mimotope database and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Conformational B-cell epitope prediction method based on antigen preprocessing and mimotopes analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Understanding the mechanism of atovaquone drug resistance in Plasmodium falciparum cytochrome b mutation Y268S using computational methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

A hybrid approach for predicting promiscuous MHC class I restricted T cell epitopes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Selection and combination of machine learning classifiers for prediction of linear B-cell epitopes on proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

A systematic assessment of MHC class II peptide binding predictions and evaluation of a consensus approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

A consensus epitope prediction approach identifies the breadth of murine T(CD8+)-cell responses to vaccinia virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Recent advances in B-cell epitope prediction methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Predicting population coverage of T-cell epitope-based diagnostics and vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

In silico CD4+ T-cell epitope prediction and HLA distribution analysis for the potential proteins of Neisseria meningitidis Serogroup B--a clue for vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

In silico accelerated identification of structurally conserved CD8+ and CD4+ T-cell epitopes in high-risk HPV types

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Ethnicity-tailored novel set of ESAT-6 peptides for differentiating active and latent tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Tapping CD4 T cells for cancer immunotherapy: the choice of personalized genomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

A dynamic inflammatory cytokine network in the human ovarian cancer microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Nonlinear dynamics of immunogenic tumors: parameter estimation and global bifurcation analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Pattern formation and spatiotemporal irregularity in a model for macrophage-tumour interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Modeling protective anti-tumor immunity via preventative cancer vaccines using a hybrid agent-based and delay differential equation approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Mixed immunotherapy and chemotherapy of tumors: modeling, applications and biological interpretations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

A mathematical model of the enhancement of tumor vaccine efficacy by immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Trends in modeling Biomedical Complex Systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

How many dendritic cells are required to initiate a T-cell response?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Therapeutically targeting ErbB3: a key node in ligand-induced activation of the ErbB receptor-PI3K axis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

MM-141, an IGF-IR- and ErbB3-directed bispecific antibody, overcomes network adaptations that limit activity of IGF-IR inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Pharmacodynamics: biological activity of targeted therapies in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Antibody therapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Cancer immunotherapy, mathematical modeling and optimal control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Modeling the competition between lung metastases and the immune system using agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Searching of optimal vaccination schedules: application of genetic algorithms to approach the problem in cancer immunoprevention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

In silico modeling and in vivo efficacy of cancer-preventive vaccinations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Exploiting the mutanome for tumor vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Predictive gene signature in MAGE-A3 antigen-specific cancer immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Predicting outcomes of prostate cancer immunotherapy by personalized mathematical models

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Improving T-cell immunotherapy for melanoma through a mathematically motivated strategy: efficacy in numbers?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Reconsidering the paradigm of cancer immunotherapy by computationally aided real-time personalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Feedback control of T-cell receptor activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Integrating signals from the T-cell receptor and the interleukin-2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Phenotypic model for early T-cell activation displaying sensitivity, specificity, and antagonism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Transcriptional regulation of germinal center B and plasma cell fates by dynamical control of IRF4

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Understanding natural killer cell regulation by mathematical approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Kinetic modeling-based detection of genetic signatures that provide chemoresistance via the E2F1-p73/DNp73-miR-205 network

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Immunological network signatures of cancer progression and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

QSAR and the Prediction of T-Cell Epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

A general framework for modeling tumor-immune system competition and immunotherapy: Mathematical analysis and biomedical inferences

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

Integration of sensitivity and bifurcation analysis to detect critical processes in a model combining signalling and cell population dynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBV046

21 January 2018

Identifiers

DOI

10.1093/BIB/BBV046

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26174229%20AND%20SRC:MED&resulttype=core&format=json

journals/bib/GuptaJSSWV16

14 June 2020

DBLP publication ID

1 reference

DBLP Dataset 2021-01-02

28 January 2021

1 reference